ANG Lifesciences India Share Price

BSE
ANG •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in ANG Lifesciences India Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
Near 52W Low of ₹44.38
-7.1
TTM PE Ratio
Negative PE TTM
-3.9
Price to Book Ratio
Low in industry
0.8
Dividend yield 1yr %
0
TTM PEG Ratio
0

ANG Lifesciences India Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Jun 2024 - 18.41 Cr Mar 2024 - 146.81 Cr
Mar 2024 - 37.84 Cr Mar 2023 - 229.61 Cr
Dec 2023 - 18.55 Cr Mar 2022 - 355.2 Cr
Sep 2023 - 33.26 Cr - Cr
Jun 2023 - 56.46 Cr - Cr
Net Profit/Loss
QuarterlyYearly
Jun 2024 - -3.07 Cr Mar 2024 - -10.14 Cr
Mar 2024 - -3.65 Cr Mar 2023 - -0.26 Cr
Dec 2023 - -5.93 Cr Mar 2022 - 40.32 Cr
Sep 2023 - -2.32 Cr - Cr
Jun 2023 - 1.75 Cr - Cr

ANG Lifesciences India Ltd shareholding Pattern

Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%
Promoter
70.6%
Public
29.4%

ANG Lifesciences India Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
45.20
10Day EMA
45.70
12Day EMA
45.90
20Day EMA
46.60
26Day EMA
47.10
50Day EMA
48.40
100Day EMA
50.40
200Day EMA
55.20
5Day SMA
44.90
10Day SMA
45.90
20Day SMA
46.60
30Day SMA
47.60
50Day SMA
49.80
100Day SMA
50.00
150Day SMA
51.60
200Day SMA
54.00
Delivery & Volume
Day
Combined Delivery Volume- 2092 Rs
NSE+BSE Traded Volume- 2278 Rs

Week
Combined Delivery Volume- 5396 Rs
NSE+BSE Traded Volume- 7912 Rs

Month
Combined Delivery Volume- 4479 Rs
NSE+BSE Traded Volume- 7466 Rs

Resistance & Support
45.46
Pivot
Resistance
First Resistance
46.41
Second Resistance
47.91
Third Resistance
48.86
Support
First Support
43.96
Second support
43.01
Third Support
41.51
Relative Strength Index
37.93
Money Flow Index
42.41
MACD
-1.25
MACD Signal
-1.19
Average True Range
2.31
Average Directional Index
14.96
Rate of Change (21)
-9.01
Rate of Change (125)
-20.40

ANG Lifesciences India Ltd Company background

Founded in: 2006
Managing director: Rajesh Gupta
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name ANG Lifesciences India Private Limited on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to ANG Lifesciences India Private Limited on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to ANG Lifesciences India Limited on May 18, 2016.The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 200809, the Company started its commercial production. In 201415, it commenced direct sale of medicines covering hospitals , Doctors through stockists. The Company is ISO9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing setup consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. These stateofart facilities have integrated process development teams with inhouse engineering capabilities and well equipped with quality control laboratories with most modern and validate analytical equipment. It also has geographical presence across India, Africa, Gulf countries other ROW countries.In August, 2017, the Company came up with a Public Issue of 15,00,800 Equity Shares by raising money from public aggregating to Rs 12 Crore. The Company acquired Mansa Printers Publishers Limited in April, 2021 for backward integration in pharma packaging to optimize costs and ensure timely availability of packaging products.
Read More

ANG Lifesciences India Ltd FAQs

You can easily buy ANG Lifesciences India Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -